STIM
Neuronetics, Inc.
Price Chart
Latest Quote
$1.23
+0.02 (+1.65%)
Current Price
| Previous Close | $1.21 |
| Open | $1.23 |
| Day High | $1.30 |
| Day Low | $1.20 |
| Volume | 1,612,670 |
Stock Information
| Shares Outstanding | 69.59M |
| Total Debt | $85.39M |
| Cash Equivalents | $13.21M |
| Revenue | $151.64M |
| Net Income | $-37.11M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $85.59M |
| EPS (TTM) | $-0.54 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $159.47M |
| Sales | $151.64M |
| Income | $-37.11M |
| Book/sh | $0.19 |
| Cash/sh | $0.19 |
| Employees | 658 |
Financial Ratios
| Quick Ratio | 1.03 |
| Current Ratio | 1.67 |
| Debt/Eq | 500.52 |
Returns & Margins
| ROA | -13.56% |
| ROE | -131.56% |
| Gross Margin | 48.22% |
| Operating Margin | -26.11% |
| Profit Margin | -24.48% |
Ownership
| Insider Ownership | 32.46% |
| Institutional Ownership | 59.86% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.65 |
| P/S | 0.56 |
| P/B | 6.44 |
Analyst Data
| Recommendation | none |
| Target Price | $4.33 |
Technical Indicators
| SMA20 | $1.33 |
| SMA50 | $1.47 |
| SMA200 | $1.86 |
| RSI | 33.68 |
| ATR | 0.1291 |
| Shares Float | 30.67M |
| Short Float | 28.76% |
| Short Ratio | 3.21 |
| Volatility | 1.04 |
| Rel Volume | 0.95 |
Performance History
| Week | -6.11% |
| Month | +4.24% |
| Quarter | -18.81% |
| 6 Months | -25.45% |
| YTD | -14.58% |
| Year | -64.76% |
| 3 Years | -48.10% |
| 5 Years | -92.13% |
| 10 Years | -95.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.23 | 1,650,500 |
| 2026-06-17 | $1.21 | 1,676,900 |
| 2026-06-16 | $1.20 | 1,892,000 |
| 2026-06-15 | $1.27 | 1,228,300 |
| 2026-06-12 | $1.33 | 916,000 |
| 2026-06-11 | $1.31 | 681,700 |
| 2026-06-10 | $1.24 | 493,800 |
| 2026-06-09 | $1.24 | 1,275,100 |
| 2026-06-08 | $1.28 | 1,229,700 |
| 2026-06-05 | $1.29 | 2,009,900 |
| 2026-06-04 | $1.46 | 1,048,900 |
| 2026-06-03 | $1.39 | 1,833,300 |
| 2026-06-02 | $1.56 | 1,117,900 |
| 2026-06-01 | $1.67 | 2,537,900 |
| 2026-05-29 | $1.54 | 1,597,200 |
| 2026-05-28 | $1.54 | 3,478,600 |
| 2026-05-27 | $1.22 | 2,068,700 |
| 2026-05-26 | $1.22 | 3,082,600 |
| 2026-05-22 | $1.20 | 2,586,500 |
| 2026-05-21 | $1.19 | 2,284,600 |
| 2026-05-20 | $1.19 | 3,960,300 |
| 2026-05-19 | $1.18 | 3,231,300 |
About Neuronetics, Inc.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
đ° Latest News
Neuronetics Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T21:07:06Z
Neuronetics, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T20:55:23Z
Neuronetics (STIM) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-05T20:20:10Z
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-05T13:15:08Z
How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target
Simply Wall St. âĸ 2026-05-02T14:14:17Z
How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions
Simply Wall St. âĸ 2026-04-18T11:07:18Z
How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions
Simply Wall St. âĸ 2026-04-03T08:12:00Z
Neuronetics, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-17T16:46:48Z
Neuronetics (STIM) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-03-17T15:02:49Z
Neuronetics Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-17T14:02:04Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $76,849,000 | $20,729,000 | $19,643,000 | $15,483,000 |
| Cost Of Revenue | $76,849,000 | $20,729,000 | $19,643,000 | $15,483,000 |
| Total Revenue | $149,157,000 | $74,890,000 | $71,348,000 | $65,206,000 |
| Operating Revenue | $149,157,000 | $74,890,000 | $71,348,000 | $65,206,000 |
| Expenses | ||||
| Interest Expense | $7,600,000 | $6,500,000 | $4,800,000 | $3,600,000 |
| Total Expenses | $180,593,000 | $109,453,000 | $101,902,000 | $100,317,000 |
| Other Income Expense | $716,000 | $-1,878,000 | $5,789,000 | $2,203,000 |
| Other Non Operating Income Expenses | $716,000 | $2,549,000 | $5,789,000 | $2,203,000 |
| Net Non Operating Interest Income Expense | $-8,400,000 | $-7,300,000 | $-5,400,000 | $-4,300,000 |
| Total Other Finance Cost | $800,000 | $800,000 | $600,000 | $700,000 |
| Interest Expense Non Operating | $7,600,000 | $6,500,000 | $4,800,000 | $3,600,000 |
| Operating Expense | $103,744,000 | $88,724,000 | $82,259,000 | $84,834,000 |
| Selling And Marketing Expense | $47,458,000 | $45,631,000 | $47,318,000 | $49,982,000 |
| General And Administrative Expense | $49,702,000 | $30,322,000 | $25,426,000 | $25,516,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-38,998,000 | $-43,708,000 | $-30,189,000 | $-37,159,000 |
| Net Interest Income | $-8,400,000 | $-7,300,000 | $-5,400,000 | $-4,300,000 |
| Normalized Income | $-38,998,000 | $-39,281,000 | $-30,189,000 | $-37,159,000 |
| Net Income From Continuing And Discontinued Operation | $-38,998,000 | $-43,708,000 | $-30,189,000 | $-37,159,000 |
| Total Operating Income As Reported | $-31,436,000 | $-34,563,000 | $-30,554,000 | $-35,111,000 |
| Net Income Common Stockholders | $-38,998,000 | $-43,708,000 | $-30,189,000 | $-37,159,000 |
| Net Income | $-38,998,000 | $-43,708,000 | $-30,189,000 | $-37,159,000 |
| Net Income Including Noncontrolling Interests | $-39,120,000 | $-43,741,000 | $-30,165,000 | $-37,208,000 |
| Net Income Continuous Operations | $-39,120,000 | $-43,741,000 | $-30,165,000 | $-37,208,000 |
| Pretax Income | $-39,120,000 | $-43,741,000 | $-30,165,000 | $-37,208,000 |
| Special Income Charges | $0 | $-4,427,000 | $0 | $0 |
| Operating Income | $-31,436,000 | $-34,563,000 | $-30,554,000 | $-35,111,000 |
| Gross Profit | $72,308,000 | $54,161,000 | $51,705,000 | $49,723,000 |
| Per Share | ||||
| Diluted EPS | $-0.59 | $-1.37 | $-1.05 | $-1.38 |
| Basic EPS | $-0.59 | $-1.37 | $-1.05 | $-1.38 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-28,055,000 | $-30,741,000 | $-23,359,000 | $-31,960,000 |
| Total Unusual Items | $0 | $-4,427,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $-4,427,000 | $0 | $0 |
| Reconciled Depreciation | $3,465,000 | $2,073,000 | $2,006,000 | $1,648,000 |
| EBITDA (Bullshit earnings) | $-28,055,000 | $-35,168,000 | $-23,359,000 | $-31,960,000 |
| EBIT | $-31,520,000 | $-37,241,000 | $-25,365,000 | $-33,608,000 |
| Diluted Average Shares | $65,951,000 | $31,626,000 | $28,658,000 | $26,900,000 |
| Basic Average Shares | $65,951,000 | $31,626,000 | $28,658,000 | $26,900,000 |
| Diluted NI Availto Com Stockholders | $-38,998,000 | $-43,708,000 | $-30,189,000 | $-37,159,000 |
| Minority Interests | $137,000 | $19,000 | $0 | $0 |
| Research And Development | $6,584,000 | $12,771,000 | $9,515,000 | $9,336,000 |
| Selling General And Administration | $97,160,000 | $75,953,000 | $72,744,000 | $75,498,000 |
| Other Gand A | $49,702,000 | $30,322,000 | $25,426,000 | $25,516,000 |
| Other Special Charges | - | $4,427,000 | - | - |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-19,393,000 | $-10,534,000 | $34,190,000 | $57,060,000 |
| Total Assets | $141,551,000 | $140,903,000 | $115,831,000 | $116,884,000 |
| Total Non Current Assets | $80,000,000 | $82,781,000 | $22,038,000 | $18,115,000 |
| Other Non Current Assets | $1,982,000 | $1,923,000 | $4,430,000 | $3,645,000 |
| Non Current Prepaid Assets | $7,972,000 | $8,902,000 | $8,370,000 | $7,568,000 |
| Non Current Note Receivables | $151,000 | $295,000 | $3,795,000 | $362,000 |
| Goodwill And Other Intangible Assets | $41,771,000 | $38,240,000 | $0 | - |
| Other Intangible Assets | $18,149,000 | $19,606,000 | - | - |
| Current Assets | $61,551,000 | $58,122,000 | $93,793,000 | $98,769,000 |
| Other Current Assets | $2,922,000 | $6,846,000 | $4,766,000 | $2,174,000 |
| Restricted Cash | $6,000,000 | $1,000,000 | $0 | - |
| Prepaid Assets | $3,050,000 | $3,078,000 | $2,514,000 | $1,997,000 |
| Inventory | $4,327,000 | $4,248,000 | $8,093,000 | $8,899,000 |
| Receivables | $16,893,000 | $24,285,000 | $17,838,000 | $13,821,000 |
| Notes Receivable | $424,000 | $930,000 | $2,056,000 | $230,000 |
| Accounts Receivable | $16,469,000 | $23,355,000 | $15,782,000 | $13,591,000 |
| Allowance For Doubtful Accounts Receivable | $-1,043,000 | $-1,930,000 | $-795,000 | $-1,648,000 |
| Gross Accounts Receivable | $17,512,000 | $25,285,000 | $16,577,000 | $15,239,000 |
| Cash Cash Equivalents And Short Term Investments | $28,359,000 | $18,665,000 | $60,582,000 | $71,878,000 |
| Cash And Cash Equivalents | $28,134,000 | $18,459,000 | $59,677,000 | $70,340,000 |
| Debt | ||||
| Net Debt | $37,673,000 | $36,692,000 | - | - |
| Total Debt | $90,303,000 | $82,628,000 | $62,474,000 | $39,745,000 |
| Long Term Debt And Capital Lease Obligation | $84,742,000 | $77,837,000 | $61,629,000 | $25,796,000 |
| Long Term Debt | $65,807,000 | $55,151,000 | $59,283,000 | $22,829,000 |
| Current Debt And Capital Lease Obligation | $5,561,000 | $4,791,000 | $845,000 | $13,949,000 |
| Current Debt | - | - | - | $13,125,000 |
| Other Current Borrowings | - | - | - | $13,125,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $115,311,000 | $109,104,000 | $81,641,000 | $59,824,000 |
| Total Non Current Liabilities Net Minority Interest | $84,790,000 | $77,839,000 | $61,829,000 | $26,625,000 |
| Non Current Deferred Liabilities | $48,000 | $2,000 | $200,000 | $829,000 |
| Current Liabilities | $30,521,000 | $31,265,000 | $19,812,000 | $33,199,000 |
| Current Deferred Liabilities | $1,253,000 | $1,974,000 | $1,620,000 | $1,980,000 |
| Payables And Accrued Expenses | $15,097,000 | $16,548,000 | $9,344,000 | $6,069,000 |
| Payables | $12,002,000 | $12,301,000 | $5,570,000 | $3,092,000 |
| Other Payable | $652,000 | $605,000 | - | - |
| Total Tax Payable | $611,000 | $619,000 | $818,000 | $659,000 |
| Accounts Payable | $10,739,000 | $11,077,000 | $4,752,000 | $2,433,000 |
| Equity | ||||
| Common Stock Equity | $22,378,000 | $27,706,000 | $34,190,000 | $57,060,000 |
| Total Equity Gross Minority Interest | $26,240,000 | $31,799,000 | $34,190,000 | $57,060,000 |
| Stockholders Equity | $22,378,000 | $27,706,000 | $34,190,000 | $57,060,000 |
| Retained Earnings | $-458,787,000 | $-419,789,000 | $-376,081,000 | $-345,892,000 |
| Other | ||||
| Ordinary Shares Number | $68,994,000 | $55,679,501 | $29,091,267 | $27,267,867 |
| Share Issued | $68,994,000 | $55,679,501 | $29,091,267 | $27,267,867 |
| Tangible Book Value | $-19,393,000 | $-10,534,000 | $34,190,000 | $57,060,000 |
| Invested Capital | $88,185,000 | $82,857,000 | $93,473,000 | $93,014,000 |
| Working Capital | $31,030,000 | $26,857,000 | $73,981,000 | $65,570,000 |
| Capital Lease Obligations | $24,496,000 | $27,477,000 | $3,191,000 | $3,791,000 |
| Total Capitalization | $88,185,000 | $82,857,000 | $93,473,000 | $79,889,000 |
| Minority Interest | $3,862,000 | $4,093,000 | $0 | - |
| Additional Paid In Capital | $480,475,000 | $446,938,000 | $409,980,000 | $402,679,000 |
| Capital Stock | $690,000 | $557,000 | $291,000 | $273,000 |
| Common Stock | $690,000 | $557,000 | $291,000 | $273,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $48,000 | $2,000 | $200,000 | $829,000 |
| Long Term Capital Lease Obligation | $18,935,000 | $22,686,000 | $2,346,000 | $2,967,000 |
| Current Deferred Revenue | $753,000 | $974,000 | $1,620,000 | $1,980,000 |
| Current Capital Lease Obligation | $5,561,000 | $4,791,000 | $845,000 | $824,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $8,610,000 | $7,952,000 | $8,003,000 | $11,201,000 |
| Current Accrued Expenses | $3,095,000 | $4,247,000 | $3,774,000 | $2,977,000 |
| Investments And Advances | $98,000 | $86,000 | $661,000 | $1,222,000 |
| Other Investments | $98,000 | $86,000 | $661,000 | $1,222,000 |
| Goodwill | $23,622,000 | $18,634,000 | $0 | - |
| Net PPE | $28,026,000 | $33,335,000 | $4,782,000 | $5,318,000 |
| Accumulated Depreciation | $-4,052,000 | $-3,244,000 | $-2,822,000 | $-3,057,000 |
| Gross PPE | $32,078,000 | $36,579,000 | $7,604,000 | $8,375,000 |
| Leases | $1,608,000 | $1,608,000 | $1,436,000 | $1,435,000 |
| Other Properties | $29,079,000 | $28,922,000 | $4,568,000 | $4,674,000 |
| Machinery Furniture Equipment | $1,391,000 | $6,049,000 | $1,600,000 | $2,266,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $225,000 | $206,000 | $905,000 | $1,538,000 |
| Current Provisions | - | - | - | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-21,175,000 | $-32,463,000 | $-34,407,000 | $-34,008,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-20,374,000 | $-30,997,000 | $-32,038,000 | $-30,739,000 |
| Cash Flow From Continuing Operating Activities | $-20,374,000 | $-30,997,000 | $-32,038,000 | $-30,739,000 |
| Operating Gains Losses | $72,000 | $4,455,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-801,000 | $-1,466,000 | $-2,369,000 | $-3,269,000 |
| Investing Cash Flow | $-801,000 | $-2,413,000 | $-1,322,000 | $6,731,000 |
| Cash Flow From Continuing Investing Activities | $-801,000 | $-2,413,000 | $-1,322,000 | $6,731,000 |
| Net Other Investing Changes | - | $1,606,000 | $1,047,000 | $10,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,731,000 | $0 | $0 | - |
| Issuance Of Capital Stock | $29,013,000 | $0 | $0 | $0 |
| Financing Cash Flow | $35,850,000 | $-6,808,000 | $22,697,000 | $207,000 |
| Cash Flow From Continuing Financing Activities | $35,850,000 | $-6,808,000 | $22,697,000 | $207,000 |
| Net Other Financing Charges | $-1,234,000 | $-6,809,000 | $-1,104,000 | $-91,000 |
| Net Common Stock Issuance | $27,282,000 | $0 | $0 | $0 |
| Common Stock Issuance | $29,013,000 | $0 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-211,000 | $-60,000,000 | $-1,200,000 | $0 |
| Issuance Of Debt | $10,000,000 | $57,479,000 | $25,000,000 | $0 |
| Interest Paid Supplemental Data | $7,591,000 | $6,513,000 | $4,790,000 | $3,543,000 |
| End Cash Position | $34,134,000 | $19,459,000 | $59,677,000 | $70,340,000 |
| Beginning Cash Position | $19,459,000 | $59,677,000 | $70,340,000 | $94,141,000 |
| Changes In Cash | $14,675,000 | $-40,218,000 | $-10,663,000 | $-23,801,000 |
| Proceeds From Stock Option Exercised | $13,000 | $2,522,000 | $1,000 | $298,000 |
| Common Stock Payments | $-1,731,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $9,789,000 | $-2,521,000 | $23,800,000 | $0 |
| Net Long Term Debt Issuance | $9,789,000 | $-2,521,000 | $23,800,000 | $0 |
| Long Term Debt Payments | $-211,000 | $-60,000,000 | $-1,200,000 | $0 |
| Long Term Debt Issuance | $10,000,000 | $57,479,000 | $25,000,000 | $0 |
| Net Business Purchase And Sale | $0 | $-2,553,000 | $0 | $0 |
| Purchase Of Business | $0 | $-2,553,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-801,000 | $-1,466,000 | $-2,369,000 | $-3,269,000 |
| Purchase Of PPE | $-801,000 | $-1,466,000 | $-2,369,000 | $-3,269,000 |
| Change In Working Capital | $6,577,000 | $-6,808,000 | $-14,103,000 | $-5,116,000 |
| Change In Other Working Capital | $-175,000 | $-843,000 | $-989,000 | $-1,164,000 |
| Change In Other Current Liabilities | $257,000 | $-66,000 | $0 | $0 |
| Change In Other Current Assets | $-31,000 | $997,000 | $1,193,000 | $1,114,000 |
| Change In Payables And Accrued Expense | $-2,252,000 | $-4,068,000 | $-214,000 | $4,636,000 |
| Change In Accrued Expense | $-502,000 | $-2,083,000 | $-2,243,000 | $6,604,000 |
| Change In Payable | $-1,750,000 | $-1,985,000 | $2,029,000 | $-1,968,000 |
| Change In Account Payable | $-1,750,000 | $-1,985,000 | $2,029,000 | $-1,968,000 |
| Change In Prepaid Assets | $5,632,000 | $-2,251,000 | $-4,164,000 | $-457,000 |
| Change In Inventory | $-395,000 | $3,150,000 | $-1,098,000 | $-2,587,000 |
| Change In Receivables | $3,541,000 | $-3,727,000 | $-8,831,000 | $-6,658,000 |
| Changes In Account Receivables | $3,541,000 | $-3,727,000 | $-8,831,000 | $-6,658,000 |
| Other Non Cash Items | $824,000 | $771,000 | $634,000 | $801,000 |
| Stock Based Compensation | $6,848,000 | $5,602,000 | $7,319,000 | $8,746,000 |
| Provisionand Write Offof Assets | $587,000 | $2,055,000 | $390,000 | $341,000 |
| Asset Impairment Charge | $388,000 | $4,582,000 | $1,905,000 | $0 |
| Depreciation Amortization Depletion | $3,465,000 | $2,073,000 | $2,006,000 | $1,648,000 |
| Depreciation And Amortization | $3,465,000 | $2,073,000 | $2,006,000 | $1,648,000 |
| Gain Loss On Sale Of PPE | $72,000 | $28,000 | $0 | $0 |
| Net Income From Continuing Operations | $-39,135,000 | $-43,727,000 | $-30,189,000 | $-37,159,000 |
| Net Investment Purchase And Sale | - | - | - | $10,000,000 |
Fetched: 2026-06-16